Anavex Life Sciences
AVXL
AVXL
70 hedge funds and large institutions have $36.8M invested in Anavex Life Sciences in 2020 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 25 increasing their positions, 15 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
4.87% less ownership
Funds ownership: 24.8% → 19.93% (-4.9%)
88% less call options, than puts
Call options by funds: $243K | Put options by funds: $1.98M
Holders
70
Holding in Top 10
1
Calls
$243K
Puts
$1.98M
Top Buyers
| 1 | +$1.03M | |
| 2 | +$1.01M | |
| 3 | +$757K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$329K |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
+$320K |
Top Sellers
| 1 | -$8.73M | |
| 2 | -$1.04M | |
| 3 | -$191K | |
| 4 |
Simplex Trading
Chicago,
Illinois
|
-$185K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$176K |